About Pandorum
Pandorum is a company based in Bengaluru (India) founded in 2011 by Tuhin Bhowmick and Arun Chandru.. Pandorum has raised $46.82 million across 13 funding rounds from investors including Kotak Mahindra Bank, We Founder Circle and 021 Capital. The company has 27 employees as of December 13, 2024. Pandorum offers products and services including Bioengineered Cornea, Mini Liver, Lung Regeneration, and Technology Platform. Pandorum operates in a competitive market with competitors including Ensoma, Avita Medical, Newcells Biotech, Organogenesis and InSphero, among others.
- Headquarter Bengaluru, India
- Employees 27 as on 13 Dec, 2024
- Founders Tuhin Bhowmick, Arun Chandru
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pandorum Technologies Private Limited
- Date of Incorporation 16 May, 2011
- Jurisdiction Bengaluru, Karnataka, India
-
Annual Revenue
$84.39 K (USD)301.44as on Mar 31, 2024
-
Net Profit
$-1.51 M (USD)19.88as on Mar 31, 2024
-
EBITDA
$-1.46 M (USD)13.84as on Mar 31, 2024
-
Total Equity Funding
$46.82 M (USD)
in 13 rounds
-
Latest Funding Round
$10 M (USD), Series B
Nov 27, 2025
-
Investors
Kotak Mahindra Bank
& 70 more
-
Employee Count
27
as on Dec 13, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pandorum
Pandorum offers a comprehensive portfolio of products and services, including Bioengineered Cornea, Mini Liver, Lung Regeneration, and Technology Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treats corneal disorders through regenerative tissue therapy
Supports drug discovery using human liver organoids
Repairs lung damage via exosomal therapy
Enables tissue fabrication for research applications
Funding Insights of Pandorum
Pandorum has successfully raised a total of $46.82M across 13 strategic funding rounds. The most recent funding activity was a Series B round of $10 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Series B — $10.0M
- First Round First Round
- Investors Count 71
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Series B - Pandorum | Valuation |
investors |
|
| Aug, 2023 | Amount | Series A - Pandorum | Valuation | Ashish Kacholia | |
| Aug, 2023 | Amount | Series A - Pandorum | Valuation | We Founder Circle |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Pandorum
Pandorum has secured backing from 71 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include Kotak Mahindra Bank, We Founder Circle and 021 Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Angel investor network investing in early-stage startups
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Investment in early-stage startups and global community support.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pandorum
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Pandorum
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pandorum Comparisons
Competitors of Pandorum
Pandorum operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ensoma, Avita Medical, Newcells Biotech, Organogenesis and InSphero, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of in vivo stem cell modification technologies and vector-based drug delivery tool
|
|
| domain | founded_year | HQ Location |
Products for regenerative and respiratory medicine are developed and distributed.
|
|
| domain | founded_year | HQ Location |
Induced pluripotent stem cell-derived organoid models are developed for research.
|
|
| domain | founded_year | HQ Location |
Regenerative therapies for wound care are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Cell-based assays and 3D microtissues for drug screening are developed.
|
|
| domain | founded_year | HQ Location |
Developer of stem cells and organoids using proprietary technology
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pandorum
Frequently Asked Questions about Pandorum
When was Pandorum founded?
Pandorum was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is Pandorum located?
Pandorum is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Who is the current CEO of Pandorum?
Tuhin Bhowmick is the current CEO of Pandorum. They have also founded this company.
Is Pandorum a funded company?
Pandorum is a funded company, having raised a total of $46.82M across 13 funding rounds to date. The company's 1st funding round was a Series A of $1.56M, raised on Jun 01, 2012.
How many employees does Pandorum have?
As of Dec 13, 2024, the latest employee count at Pandorum is 27.
What is the annual revenue of Pandorum?
Annual revenue of Pandorum is $84.39K as on Mar 31, 2024.
What does Pandorum do?
Pandorum was founded in 2011 in Bengaluru, India, within the biotechnology sector. Focus is placed on regenerative medicine through 3D printing and fabrication techniques. Products developed include a bioengineered cornea hydrogel for treating blindness, 3D hepatocyte spheroids for drug discovery and liver therapies, and exosome-based cell-free treatments for lung regeneration. Operations center on advancing tissue engineering solutions.
Who are the top competitors of Pandorum?
Pandorum's top competitors include Avita Medical, Newcells Biotech and InSphero.
What products or services does Pandorum offer?
Pandorum offers Bioengineered Cornea, Mini Liver, Lung Regeneration, and Technology Platform.
Who are Pandorum's investors?
Pandorum has 71 investors. Key investors include Kotak Mahindra Bank, We Founder Circle, 021 Capital, KITVEN, and BTB Venture.
What is Pandorum's valuation?
The valuation of Pandorum is $40.67M as of Aug 2023.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.